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Abstract
Background: Liposuction can remove a substantial amount of body fat. We in-
vestigated the effects of liposuction of large volumes of fat on anthropometrics, 
body composition (BIA), metabolic hormones, and psychological measures in 
overweight/obese women. To our knowledge, this is the first study to examine both 
physiological and psychological changes following liposuction of large volumes 
of fat in humans. 
Method: Nine premenopausal healthy overweight/obese women (age = 35.9 ± 
7.1 SD, weight = 84.4 kg ± 13.6, BMI = 29.9 kg/m2 ± 2.9) underwent liposuction, 
removing 3.92 kg ± 1.04 SD of fat. Following an overnight fast, height, weight, 
waist, and hip circumferences were measured at baseline (one week pre-surgery) 
and post-surgery (wk 1,4,12). Blood samples were drawn for fasting concen-
trations of glucose, insulin, leptin, and ghrelin. The Body Shape Questionnaire 
(BSQ), Body Dysmorphic Disorder (BDD) Examination Self-Report (BDDE-SR), 
and Zung Self-Rating Depression Scale (ZDS) were administered. 
Results: Body weight, BMI, waist circumference, and body fat consistently de-
creased over time (p < .05). Glucose did not change significantly, but insulin de-
creased from wk 1 to wk 12 (p < .05). Leptin decreased from baseline to wk 1 (p 
= .01); ghrelin increased but not significantly. Changes in body fat and waist cir-
cumference (baseline to wk 1) correlated positively with changes in insulin during 
that period, and correlated inversely with changes in ghrelin (p < .05). BSQ scores 
decreased significantly over time (p = .004), but scores for BDDE-SR  (p = .10) 
and ZDS (p = .24) did not change significantly. 
Conclusion: Liposuction led to significant decreases in body weight and fat, waist 
circumference, and leptin levels. Changes in body fat and waist circumference 
correlated with concurrent changes in the adipose-related hormones, insulin and 
ghrelin (baseline to wk 1), and body shape perception improved. Thus, besides the 
obvious cosmetic effects, liposuction led to several positive body composition, 
hormonal, and psychological changes.
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Introduction
 
 Obesity has become an epidemic in the United States and is associated with various comorbidities, such as cardiovascular 
disease and insulin resistance[1]. Although more closely associated with visceral adipose tissue (VAT), insulin resistance is also cor-
related with subcutaneous adipose tissue (SAT)[2,3]. Despite availability of a variety of weight-loss techniques, including exercise, 
diet, and behavioral therapy, such lifestyle modifications remain a challenge for many, and most individuals regain much of the lost 
weight over time[4]. An alternative to diet-induced weight loss is bariatric surgery, which can lead to marked sustained reductions 
in body weight and fat. However, it is restricted to clinically severe obese individuals (BMI ≥ 40 without associated comorbidity or 
BMI ≥ 35 with comorbidity). Another surgical option is to undergo liposuction, which is defined by The American Society of Plastic 
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2Surgeons as a procedure that removes excess fat deposits and 
improves the body contours and proportions[5], which may also 
yield some potential metabolic benefits. 
 Results from previous literature have, however, been 
inconsistent about metabolic changes following liposuction. 
Giese et al. found that liposuction of large volumes of fat led to 
a reduction in fasting plasma insulin and systolic blood pressure, 
along with decreases in body weight and fat mass, but without 
changes in fasting glucose, leptin, lipid profiles, or resting en-
ergy expenditure[6]. Two other studies found that liposuction of 
large volumes of fat decreased insulin resistance[7,8], glucose, 
and cholesterol[8]. A fourth study, however, failed to show that 
liposuction significantly altered plasma glucose, insulin, insulin 
resistance, blood pressure, or lipid concentrations despite a 44% 
decrease of subcutaneous abdominal adipose tissue by volume[9].
 The hormone leptin is secreted by adipose tissue, and 
thus plasma levels are elevated in obese individuals, but these 
individuals tend to be leptin resistant and do not benefit from 
leptin’s ability to suppress appetite[10]. On the other hand, levels 
of the orexigenic hormone ghrelin, associated with meal initia-
tion and hunger, are lower in obesity[11-14]. Fasting ghrelin usual-
ly increases after diet-induced weight loss, but tends to decrease 
after gastric bypass surgery, which may be a contributing factor 
to reduced appetite post-surgery[15]. In obese male Zucker rats, 
ghrelin decreased following liposuction[16], similar to decreased 
ghrelin levels after gastric bypass surgery[17]. However, in hu-
mans, it has been observed that ghrelin levels generally increase 
when body fat decreases[15].
 Following weight loss, there is a homeostatic drive to 
restore the lost weight[18], which can be accompanied by behav-
ioral and psychological changes19,20]. Weight reduction has some-
times been associated with an increase in depressed mood and 
preoccupation with body weight, food, and hunger[21]. Among 
those successful at maintaining weight loss, however, psycho-
logical scores of depression and psychological distress gener-
ally have not increased[22]. Such psychological changes have 
not been investigated in individuals undergoing liposuction of 
large volumes of fat. In studies following other forms of cosmet-
ic surgery, depression levels did not change post surgery[23,24]. 
About 3-15% of those seeking cosmetic surgery present with 
mild to severe Body Dysmorphic Disorder (BDD)[25-28], a neg-
ative obsession with a part of the body. Cosmetic surgery did 
not improve BDD based on clinical interviews[29] or BDD ques-
tionnaire scores[30], and did not help prevent the development of 
BDD in those with mild or sub-threshold BDD[31]. These studies, 
however, did not examine the effects of liposuction on BDD[30]. 
BDD has been shown to be overrepresented in those seeking 
liposuction[32], suggesting a need to assess BDD following lipo-
suction of large volumes of fat.
 Body shape dissatisfaction is generally greater in 
obese than lean women but can also serve as a motivator for 
weight loss[33,34]. Interventions to reduce body weight, including 
bariatric surgery, improved body image in the overweight and 
obese[33-39]. Furthermore, there is some evidence that body image 
improves following obesity treatment, independent of the degree 
of weight loss[40,41].
 Although there are studies on the psychological effects 
of weight loss and cosmetic surgery, there are none examining 
the psychological effects of the removal of large volumes of fat 
in overweight and obese individuals. In the present study, we ex-
amined changes in both physiological and psychological aspects 
following liposuction of large volumes of fat in overweight and 
obese women who had approximately 4 kg of subcutaneous fat 
tissue removed. To our knowledge, this is also the first study 
to measure ghrelin levels in humans following liposuction. We 
hypothesized that glucose, insulin, and leptin levels would de-
crease and ghrelin levels would increase following liposuction. 
We also expected that scores of depression, body dysmorphic 
disorder, and body shape dissatisfaction would improve.
Materials and Methods
Subjects
 Nine obese and overweight women (BMI = 29.9 ± 
2.9 SD) underwent liposuction removing a large volume of fat 
(Table-1). Four participants had more than four liters (L) of fat 
removed, considered large volume liposuction (LVL), four par-
ticipants had just under 4L of fat removed and one participant 
had 2.3 L removed, with a range of fat aspirate of 2.3 - 5.9L.
All women were premenopausal, and were not pregnant or using 
birth control. They had no history of cardiac, renal, gastroin-
testinal or endocrine disease, including diabetes. Patients were 
recruited by the surgeon (SG) over a seven-month period from 
the regular pool of patients visiting the office and signed an ap-
proved IRB consent form. Their racial and ethnic distribution, 
based on self-report, was 22% white, 22% Hispanic, 44% black, 
and 11% other. Patients were not requested to change their eat-
ing or exercise habits prior to or after surgery. 
Table 1: Preoperative Anthropometric Measures in Nine Over-
weight Women
Measure Range Mean ± SD
Age (y) 23 - 46 35.9 ± 7.1
Preoperative Weight (kg) 66.9 - 110.5 84.3 ± 29.0
Height (m) 1.6 - 1.8 1.7 ± 0.1
Body Mass Index (kg/m²) 26.7 - 36.0 29.9 ± 2.9
Waist Circumference (cm) 86.0 - 112.0 95.6 ± 9.2
Hip Circumference (cm) 96.0 - 132.0 109.3 ± 11.5
Liposuction: All patients underwent subcutaneous adipose tis-
sue (SAT) liposuction of the abdomen. A super wet technique 
was used, with small volumes of fluid injected into the fatty de-
posits prior to surgery to facilitate fat removal. In order to pre-
vent excessive bleeding, dilute lidocaine and epinephrine were 
injected into the SAT. Several patients additionally had small 
amounts of SAT removed from their backs, flanks, arms, inner 
and outer thighs for additional cosmetic benefits. An internal ul-
trasound-assisted liposuction system with a 4-mm hollow bul-
let-tip probe was used. This was followed by suction, using a 
Mercedes cannula with a diameter of 4 mm and a length of 15 
mm, containing three lateral suction holes. The volume of fat 
aspirate was measured by collecting the aspirate in a container 
during suction, and allowing the fat to rise to the top and weighed 
30 min later which yielded 4358 cc ± 1155 SD. Following sur-
gery, patients were dressed in special compression garments. No 
post-surgical adverse effects were reported and inflammation 
was absent by 12 weeks.
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Materials
 Patients were tested at baseline (1 week prior to sur-
gery), and at wk 1, wk 4, and wk 12 following surgery. Fasting 
blood samples were collected at each visit to measure plasma 
insulin, glucose, leptin, and ghrelin. Blood samples were centri-
fuged, and plasma separated and stored in microtubes at -80 °C 
until analyzed. Glucose was assayed with a Beckman glucose 
analyzer (glucose oxidase method), insulin with a radioimmu-
noassay (RIA) kit from Linco (intra-assay CV = 5.5, inter-assay 
CV = 4.9), leptin with an RIA kit from Linco (intra-assay CV = 
4.8, inter-assay CV = 5.9), and total ghrelin (acylated and desac-
ylated) was assayed with an (RIA) from Phoenix Pharmaceuti-
cals (intra-assay CV = 5.2, inter-assay = 6.2). Insulin resistance 
was estimated with the homeostasis model assessment (HOMA) 
from fasting glucose and insulin concentrations: fasting insulin 
(μU/ml) x fasting glucose (mg/dL)/405. Patients completed the 
Body Shape Questionnaire (BSQ)[42], a measure of weight and 
shape concern and dissatisfaction. They also completed the Body 
Dysmorphic Diagnostic Examination Self-Report (BDDE-SR), 
a questionnaire that assesses the degree of Body Dysmorphic 
Disorder (BDD)[43] based on obsession with a specific, most dis-
tressing body part. Finally, they completed the Zung Self-Rating 
Depression Scale (ZDS)[45], selected due to its advantages of re-
verse scoring and assessment of suicidal ideation.
Sample size: Sample sizes were estimated from the most related 
studies for power = 0.80, using effect size Cohen’s d (G*Power 
3.1.) with 2-tailed α = 0.05. From a related study on biologi-
cal changes (6), following large volume liposuction, insulin de-
creased from 14.9 (mIU/ml) ± 6.5 SD pre-surgery to 7.2 ± 3.2, 
4 months post-surgery. Based on this, d = 1.37, and the mini-
mum sample size n= 7 would be needed. From a related study[46] 
on psychological changes, the Body Areas Satisfaction Scale 
(BASS) scores improved from 3.15 ± 0.64 SD to 3.50 ± 0.61, d= 
1.19, and minimum sample size n = 9. Hence, nine subjects were 
considered adequate. 
Statistics: Repeated measures ANOVA was performed over the 
four time periods. The ANOVA was checked for sphericity, and 
the degrees of freedom were adjusted when appropriate. When 
the overall F was significant (p < .05), post-hoc paired tests were 
performed. Two tailed p values < .05 were considered signifi-
cant, and p values ranging from .05 to .08 were considered to 
be a trend. Means and standard deviations (SD) are used in the 
text and tables; means and standard errors (SEM) are used in 
the figures. Missing data were interpolated as follows: When the 
baseline data was missing, it was not interpolated, and thus the 
data for that subject was not used. When the missing data were 
between two known values, the average was used for interpola-
tion. If the data was missing from week 12, or from both week 4 
and week 12, the last observation carried forward (LOCF) meth-
od was used. There were missing data for waist circumference 
and body fat measurements, and for BDD, Zung, and BSQ ques-
tionnaires, which represented 18% of the total number of pos-
sible data for those variables. None of the hormone or glucose 
values were missing. SPSS (IBM SPSS, Chicago, IL) was used 
to analyze the data.
Results
Anthropometric measurements
 Body weight decreased significantly between all time 
points (F3,24 = 20.2, p < .001; post hoc, all p’s < .03). From base-
line to wk 12, patients had a mean weight reduction of 4.7 ± 2.8 
kg (Figure 1a). BMI decreased significantly (F3,24 = 4.3, p = .02) 
from baseline to wk 1, baseline to wk 4, and wk 1 to wk 4 (post 
hoc, p = .03, .001, and .003, respectively), and from baseline to 
wk 12 (p = .06, trend). Body fat decreased significantly (F3,24 
= 13.0, p < .001) from baseline to wk 1, baseline to wk 4, and 
baseline to wk 12 (post hoc, p = .01, .01, and .003, respectively). 
Waist circumference decreased significantly over all time points 
(F3,24 = 44.5, p < .001; post hoc all p’s < .03). All the data above 
are shown in Figure 1. 
   Weeks
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4Figure 1: a) Body weight (n = 9) decreased significantly between all 
time points (F3,24 = 20.2, p < .001; post hoc, all p’s < .03) following 
liposuction.
b) Body fat decreased significantly (F3,24 = 13.0, p < .001) from preop 
baseline to wk 1, 4, and 12 (post hoc, all p ‘s < .01).
c) Waist circumference decreased significantly between all time points 
(F3,24 = 44.5, p < .001; post hoc, all p’s < .03).
d) BMI decreased significantly (F3,24 = 4.3, p = .02) from baseline to wk 
1 and to wk 4 as well as wk 1 to wk 4 (post hoc, p < .03). A trend was 
shown from baseline to wk 12 (post hoc, p = .06).
Glucose and Hormones: Fasting glucose levels (F3,24 = 0.2, p = 
0.89) and insulin resistance (HOMA) (F3,24 = 1.16, p = 0.35) did 
not change significantly over time (Figure 2a,e). Insulin levels 
decreased significantly from wk 1 to wk 12 (F3,24 = 1.4, p = 0.27; 
post hoc, p = .049) (Figure 2d). Changes between baseline and 
wk  1 in body fat correlated positively with changes in insulin 
(r = 0.7, p = .03) and inversely with changes in ghrelin (r = -0.8, 
p = .02). Furthermore, changes in waist circumference between 
baseline and wk 1 correlated with changes in insulin (r = 0.9; 
p = .01), changes in leptin (r = 0.9; p = .004), and changes in glu-
cose (r = 0.8; p = .05). There was an overall significant decrease 
in leptin levels (F3,24 = 4.1, p = 0.02) (Figure 2b). Post hoc tests 
revealed significant differences from baseline to wk 1 (p = .01), 
and trends from baseline to wk 4 (p = .08) and baseline to wk 12 
(p =. 08). Ghrelin levels did not change significantly (F3,24 = 1.7, 
p = .19), but showed a trend to decrease from wk 1 to wk 12 (p 
=. 06) (Figure 2c). Ghrelin and leptin correlated inversely with 
each other at baseline (r = -0.73, p = .03) and at wk 1(r = - 0.79, 
p = .01).
 
   Weeks
Figure 2: a) Glucose did not change significantly (F3,24 = 0.2, p = 0.89).
b) Leptin decreased significantly (F3,24 = 4.1, p = 0.02) from baseline to 
wk 1(post hoc, p = .01), and a trend from baseline to wk 4 and to wk 12 
(post hoc, p = .08 and p = .08, respectively).
c) Ghrelin did not change significantly (F3,24 = 1.7, p = .19), but it 
showed a trend to decrease from wk 1 to 12 (post hoc, p = .06).
d) Insulin decreased significantly from wk 1 to 12 (F3,24 = 1.4, p = 0.27; 
post hoc, p = .049).
e) Insulin resistance (HOMA) did not change significantly (F3,24 = 1.16, 
p = 0.35).
 The hormone data were then reanalyzed using weight 
change as a covariate in the repeated measures ANOVA. The 
previous changes in insulin and leptin levels were no longer sig-
nificant. When the amount of fat removed was entered as a co-
variate, the hormonal changes in leptin and insulin were also no 
longer significant. Furthermore, the covariates (weight change 
and fat removal) were not significant predictors on their own. 
Psychological Measures: Body Shape Questionnaire (BSQ) 
scores improved significantly (F3,18 = 6.4, p = 0.004) from base-
line to wk 4 and baseline to wk 12 (post hoc, p = .002 and 
p = .03, respectively) (Figure 3a). Body Dysmorphic Disorder 
scores (BDDE-SR) and Zung depression scores (ZDS) did not 
change significantly (F3,18 = 2.4, p = 0.1 and F3,18 = 1.5, p = 0.24, 
respectively) (Figure 3b,c; Table 2). When repeated measures 
ANOVA for BSQ scores were performed with weight change or 
fat removal as covariates, the results were no longer significant, 
and both covariates were not significant predictors on their own.
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Figure 3: a) Body Shape Questionnaire scores declined significantly 
(F3,18 = 6.4, p = 0.004) from baseline to wk 4 (post hoc, p = .002), and 
to wk 12 (post hoc, p = .03).
b) Body Dysmorphic Disorder Examination Self-Report (BDDE-SR) 
scores did not change significantly (F3,18 = 2.4, p = 0.1).
c) Zung depression scores did not change significantly (F3,18 = 1.5, p = 
0.24).
Table 2: Psychological Measures at Baseline and Postop wk 1, 
4, 12 (mean ± SD)
Baseline wk 1 wk 4 wk 12
BSQ 120.4 ± 40.3 110.5 ± 43.1 96.75 ± 34.3 92.1 ± 43.3
BDDE-SR 82.1 ± 50.2 71.4 ± 39.3 56.9 ± 27.6 51.1 ± 36.5
ZDS 33.6 ± 10.3 35.3 ± 8.2 32.6 ± 11.1 33.1 ± 12.3
BSQ, Body Shape Questionnaire
BDDE-SR, Body Dysmorphic Disorder Examination Self-Report
ZDS, Zung Self-Rating Depression Scale
Discussion
 The results showed that liposuction of large volumes 
of fat led to a significant decrease in plasma leptin levels from 
baseline to wk 1, and a significant decrease in plasma insulin 
from wk 1 to wk 12, although plasma glucose, insulin resis-
tance (HOMA), and plasma ghrelin did not change significantly. 
When weight change and amount of fat removed were entered 
as covariates, the significance was lost. This suggests that both 
weight change and amount of fat removed had an influence on 
leptin and insulin levels although the covariates did not influ-
ence the hormone levels significantly on their own. 
 Results from other studies indicate some similarities 
and differences with the present results. A study on overweight 
(BMI 27-30, age 39.4 ± 6.8 SD) women who underwent lipo-
suction of large volumes of fat revealed that they had significant 
decreases four months postoperatively in fasting plasma insulin, 
insulin resistance, and body weight and fat mass, but no sig-
nificant changes in glucose or leptin[6]. Giugliano et al. found 
that six months post liposuction of large volumes of fat, insulin 
resistance (HOMA) was significantly reduced in obese and nor-
mal-weight women, which correlated with the amount of fat re-
moved[7]. Robles-Cervantes et al. reported that three weeks post 
liposuction of large volumes of fat, 15 non-obese women had 
significant reductions in glucose and cholesterol, with increas-
es in insulin secretion, whereas insulin resistance (HOMA-IR) 
remained unaltered[8]. Klein et al., separated women into two 
groups, those with type 2 diabetes (n = 7; age, 52 ± 3) and those 
with normal glucose tolerance (n = 8; age = 42 ± 3) and did not 
find that liposuction altered plasma glucose, insulin, or insulin 
resistance significantly 10-12 weeks after surgery[9]. However, 
a number of plasma collections were made at 10 weeks, which 
may be too short a time period to observe changes in insulin.
 D’Andrea et al. studied metabolic changes following 
liposuction of large volumes of fat in 123 healthy women with 
grade 1 obesity[47]. They found that 90 days post-operatively, 
there were significant decreases in fasting plasma insulin, 2-h 
plasma glucose, insulin resistance, and plasma leptin, and that 
each factor was correlated with a decrease in fat mass and waist-
to-hip ratio. These authors also found an improvement in oxida-
tive and non-oxidative glucose metabolism, as well as lipid oxi-
dation, which they suggested as the reasons for improved insulin 
sensitivity. It is possible that we did not find an improvement in 
insulin resistance in our study due to the relatively large variance 
in insulin levels in our subjects at preoperative baseline. 
 We found that the largest change in the appetite-relat-
ed hormones leptin and ghrelin occurred at wk 1, and that the 
decrease in fat at wk 1 correlated both with leptin (positively) 
and ghrelin (inversely). This is consistent with previous find-
ings that body fat correlates positively with leptin and negatively 
with ghrelin[15]. Our study was the first to look at ghrelin levels 
following liposuction of large volumes of fat in humans, and we 
found no significant changes. 
Psychological Effects
 Liposuction of large volumes of fat led to lower scores 
in BSQ at wk 4 and wk 12 post-surgery, reflecting improvement 
in body image. Commonly, body image improves with weight 
loss[33-39]. Roughan et al. showed significant improvements in 
body image when women lost an average of 2.8 kg over 10 
weeks and another 1 kg at 2 year follow-up[33]. In a study by 
Foster et al., body image improved overall following a 48-week 
weight-loss program[35]. However, from week 24 to 48, partic-
ipants experienced a small weight gain, which was associated 
with a small, but significant worsening in body image. Other 
recent studies also showed that weight loss was associated with 
body image improvement[36-38]. In our study, after controlling for 
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6weight change and amount of fat removed, we found that both 
had a partial influence on body dissatisfaction but were not sig-
nificant predictors on their own. 
 We did not observe a change in depression scores, 
which may in part be due to the absence of high baseline scores, 
which would reflect clinical depression. The lack of change in 
depression scores is consistent with a postsurgical study for 
breast reduction[24], in which scores of depression and anxiety 
did not change[24]. Similarly, following a variety of cosmetic sur-
geries, negative thoughts, quality of life, and depression did not 
change at nine months[23].
 In our study, scores reflecting the degree of BDDE-SR 
also did not change significantly. In a review by Gipson et al. 
on various types of cosmetic surgery (rhinoplasty, breast reduc-
tion or enlargement, blepharoplasty, and hair transplants), BDD 
did not improve post-surgery[29]. Furthermore, in a prospective 
rhinoplasty study, those who presented with mild BDD pre-sur-
gery still had BDD five years post-surgery[48]. Similarly, in one 
cosmetic surgery study on seven patients with BDD, six present-
ed with BDD five years postoperatively[31]. In contrast in anoth-
er study, women undergoing a variety of cosmetic procedures 
showed decreased BDDE-SR scores six months postoperative-
ly[30]. It is possible that this decrease was due to the women being 
instructed to answer the BDDE-SR, specifically in reference to 
the feature to be altered rather than the feature that most dis-
tressed them, which is the standard protocol[30]. Results in the 
present study showed that liposuction, similar to other cosmetic 
surgeries, did not improve BDDE-SR. 
 Limitations of this study include a relatively small num-
ber of participants, although the power calculation suggested the 
number would be adequate, and the lack of a control group.
 In conclusion, this was the first study to examine both 
physiological and psychological effects of liposuction of large 
volumes of fat. We found that liposuction in overweight and 
obese women significantly reduced body weight, BMI, waist 
circumference, body fat, and plasma leptin and insulin levels. 
However, it did not significantly change glucose or ghrelin con-
centrations. Moreover, changes in body fat correlated with con-
current changes in levels of the adipose-related hormones, insu-
lin, and ghrelin from baseline to wk 1. Furthermore, changes in 
waist circumference correlated with concurrent changes in lev-
els of the adipose-related hormones, insulin and leptin, as well 
as glucose from baseline to wk 1. Liposuction of large volumes 
of fat also led to improvement in body image. Thus, liposuction 
led to several positive body composition, hormonal, and psycho-
logical changes.
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